National Institute on Drug Abuse; Notice of Closed Meetings, 1267 [2018-00219]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 7 / Wednesday, January 10, 2018 / Notices
NACDAHome.html, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–00218 Filed 1–9–18; 8:45 am]
BILLING CODE 4140–01–P
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Boulevard,
Room 4238, MSC 9550, Bethesda, MD 20892,
301–827–5820, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–00219 Filed 1–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institute on Drug Abuse;
Notice of Closed Meetings
U.S. Immigration and Customs
Enforcement
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
daltland on DSKBBV9HB2PROD with NOTICES
National Institutes of Health
[OMB Control Number 1653–0038]
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIH
Pathway to Independence Award (K99/R00).
Date: February 14, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, (301) 827–
5817, mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Pharmacogenomics of Anti-retroviral
Therapy in People Who Inject Drugs (R01).
Date: February 15, 2018.
Time: 11:00 a.m. to 1:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
VerDate Sep<11>2014
18:23 Jan 09, 2018
Jkt 244001
Agency Information Collection
Activities: Comment Request;
Extension, With Changes, of an
Information Collection
1267
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
AGENCY:
Overview of This Information
Collection
The Department of Homeland
Security (DHS), U.S. Immigration and
Customs Enforcement (USICE) is
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection notice
was previously published in the Federal
Register on September 18, 2017, Vol. 82
FR 43565, allowing for a 60-day public
comment period. USICE did not receive
any comment relating to the 60-day
notice. The purpose of this notice is to
allow an additional 30 days for public
comments.
The burden estimates have been
revised since the 60-day notice to better
reflect the number of potential
respondents to the collection. Written
comments and/or suggestions regarding
the items contained in this notice,
especially regarding the estimated
public burden and associated response
time, must be directed to the OMB Desk
Officer for U.S. Immigration and
Customs Enforcement, Department of
Homeland Security and sent via
electronic mail to dhsdeskofficer@
omb.eop.gov. All submissions received
must include the agency name and the
OMB Control Number 1653–0038.
Written comments and suggestions
from the public and affected agencies
(1) Type of Information Collection:
Extension, With Changes, of a Currently
Approved Collection.
(2) Title of the Form/Collection:
Student and Exchange Visitor
Information System (SEVIS).
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: Forms I–17
and I–20; U.S. Immigration and Customs
Enforcement.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary Non-profit institutions
and individuals or households. SEVIS is
an internet-based data-entry, collection
and reporting system. It collects
information on SEVP-certified schools
via the Form I–17, ‘‘Petition for
Approval of School for Attendance by
Nonimmigrant Student,’’ and collects
information on the F and M
nonimmigrant students that the SEVPcertified schools admit into their
programs of study via the Forms I–20s:
‘‘Certificate of Eligibility for
Nonimmigrant (F–1) Student Status—
For Academic and Language Students’’
and ‘‘Certificate of Eligibility for
Nonimmigrant (M–1) Student Status—
For Vocational Students’’.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond:
U.S. Immigration and Customs
Enforcement, Department of Homeland
Security.
ACTION: 30-day notice.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\10JAN1.SGM
10JAN1
]]>Agencies
[Federal Register Volume 83, Number 7 (Wednesday, January 10, 2018)]
[Notices]
[Page 1267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIH Pathway to Independence Award (K99/R00).
Date: February 14, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive
Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Pharmacogenomics of Anti-retroviral Therapy in
People Who Inject Drugs (R01).
Date: February 15, 2018.
Time: 11:00 a.m. to 1:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-827-5820,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00219 Filed 1-9-18; 8:45 am]
BILLING CODE 4140-01-P
